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We have found that chronic systemic maternal cortisol administration producing only a modest (1.5-fold) increase in maternal plasma cortisol concentrations also produces enlargement of the late gestation fetal heart (24, 47) . In this model, which was designed to mimic maternal cortisol responses to chronic stress, cortisol was administered over a 10-to 14-day period starting at about 110-to 120-days gestation (0.75-0.90 gestation) in the sheep. Maternal cortisol administration increased the heart weight-to-body weight ratio, thickness of both ventricular free walls and the septum, and increased myocyte proliferation through the mineralocorticoid receptor, but increased Purkinje fiber apoptosis through the glucocorticoid receptor (GR) (14, 47) . The proliferation in this model, as in the intracardiac cortisol infusion by Giraud and colleagues (21) , occurs in the absence of an increase in fetal arterial pressure. The period of maternal cortisol infusion in this study is a period of rapid fetal growth, but also one in which the fetal heart is normally transitioning from proliferation to terminal differentiation (6, 26) . Our results suggested that exposure to excess cortisol during late gestation might alter the trajectory of myocyte maturation, cardiac size, and cardiac function. However, other studies have suggested that the effects of antenatal cortisol or glucocorticoid exposure may be transitory, with recovery of fetal heart size (41, 45) .
To assess the changes in the fetal heart occurring with chronic administration of cortisol over this period of terminal differentiation and remodeling of the fetal heart, we extended the duration of the maternal infusion of cortisol from 115 days gestation to birth. We found that when the duration of cortisol exposure is extended, there is a high incidence of stillbirth or fetal death at the time of labor and delivery, resulting in stillbirth in three of four ewes allowed to deliver spontaneously (27) . In further study with this model in which the pregnancy was terminated to allow collection of fetal tissues, we were able to collect tissues from seven cortisol-infused fetal lambs and eight control fetal lambs at 139 -144 days, although there were five additional stillbirths in the cortisol-infused group. Overall there was no effect of the more prolonged maternal cortisol infusion on heart weight or dimensions. The maternal physiology in these pregnancies appeared normal in terms of uterine blood flow and estrone and progesterone concentrations, although the ewes are both hypercortisolemic and hyperglycemic (27) . Fetal demise appeared to occur late in pregnancy and appeared to be associated with the onset of labor, suggesting that the poor fetal outcome may be related to survival of the stress of labor and delivery and might be related to a functional deficit in the hearts not revealed by measurement of cardiac dimensions. To test the hypothesis that longerterm infusion of cortisol results in changes in gene expression in the heart that would reveal altered biologic processes, we undertook a transcriptomic analysis of the hearts from the four groups of fetuses: 130-day fetuses of control ewes, 130-day fetuses of cortisol-infused ewes, term fetuses of control ewes, and term fetuses of cortisol-infused ewes. We hypothesized that cortisol would produce differential gene expression at both 130 days and term, but that the pattern of induced genes would differ between the two gestational ages, with a predominance of proliferation-related genes upregulated at 130 days, but not at term, and with greater effects related to cardiac metabolism at term. We also hypothesized that some genes that are differentially regulated (DR) with maternal cortisol infusion at term would be in pathways that are activated or suppressed as an adaptive response to the earlier insult.
MATERIALS AND METHODS
Pregnant ewes and their fetuses were studied. All animal use was approved by the University of Florida Institutional Animal Care and Use Committee. Ewes were infused with cortisol (1 mg/kg/day cortisol sodium succinate; Pfizer, New York, NY) by continuous infusion; control ewes were not infused with cortisol but were otherwise similarly surgically prepared and sampled. Details of the animal use have been previously reported (14, 47) . In the first study, hearts collected from singleton fetuses after 10 days of intravenous cortisol infusion into the ewe (130-day CORT, n ϭ 6; 130 Ϯ 1 days gestation) and from control ewes (130-day CON, n ϭ 6; 130 Ϯ 1 days gestation). In the subsequent study, cortisol was infused beginning on day 115-116 of gestation, and ewes were studied until signs of early labor were evident, or by 144 days, so that euthanasia was performed at days 139 -144 of gestation. In this cohort there were seven cortisolinfused ewes with singleton fetuses (140-day CORT, n ϭ 7; 142 Ϯ 1 days gestation) and seven control ewes, one with twin fetuses (140-day CON, n ϭ 8; 143 Ϯ 1 days gestation); in each group one lamb was delivered live. Fetal hearts were excised and weighed, and samples of both ventricular free walls and septum were dissected and rapidly frozen in liquid nitrogen. The tissue samples were stored at Ϫ80 until the time of RNA extraction.
In both studies there was a significant increase in maternal cortisol produced by the infusion of cortisol. In the 130-day study fetal cortisol was increased (CORT 3.4 Ϯ 0.6 ng/ml vs CON 1.5 Ϯ 0.6 ng/ml) (47); fetuses in the study to term were not catheterized, so the values at 140 days are not available. As previously reported, maternal infusion of cortisol to 130 days increased fetal heart weight and wall thicknesses (47); however, in the studies to term neither fetal heart weight or fetal ventricular wall thicknesses were significantly increased (LV wall thickness CON, 5.2 Ϯ 0.3 mm; CORT, 5.4 Ϯ 0.3 mm; RV wall thickness CON, 4.5 Ϯ 0.3 mm; CORT, 4.6 Ϯ 0.3 mm; septal wall thickness CON, 6.7 Ϯ 0.3; CORT, 6.8 Ϯ 0.2 mm for the live lambs at term, n ϭ 7-8).
Transcriptomic analysis. We performed a transcriptomic analysis of gene expression in septal tissue by methodology previously used to identify transcriptomic responses to hypoxia in the fetal hypothalamus (64) . Septum contains two functionally significant types of myocytes, cardiomyocytes, and the specialized cardiomyocytes, Purkinje fibers, of the conductive pathway in the heart. These are both potentially critical in the resulting pathophysiology, since septal enlargement and increased caspase-3 staining in septal Purkinje cells were evident at 130 days (14, 47) , and because bradycardia at birth is observed in some clinical cases of adverse pregnancy outcome, including maternal diabetes (55, 65, 66) . Messenger RNA was extracted from septa and purified with Trizol followed by on-column DNase digestion (Qiagen RNeasy Plus kits; Qiagen Sciences, Germantown, MD). RNA integrity numbers (RIN) for the RNA samples were Ն 8.8. RNA (500 ng) was labeled with Cy5 using the Agilent QuickAmp Labeling kit to generate cRNA with specific activities of 11.45 Ϯ 0.11 pmol/g with yields of 8.67 Ϯ 0.15 g; array hybridization was performed as previously described (64) . One sample had an RIN of 7 but was not an outlier by either microarray quality control tests or probe hybridization results compared with the other microarrays, so it was included in the gene expression analyses. We used the Agilent-019921 Sheep Gene Expression Microarray 8x15k, G4813A (GPL14112) platform. The annotation of this array platform was described in a previous publication from our laboratory group (46) . The raw normalized array data for this experiment have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) (12) and are accessible through GEO Series accession number GSE54237 (http://www.ncbi.nlm. nih.gov/geo/query/acc.cgi?accϭGSE54237).
Two-way analysis of variance with treatment group and gestational age as the factors was performed with JMP Genomics 6.0 (SAS Institute, Cary, NC). Prior to analysis, features flagged as nonuniform outliers were omitted, probes with Ͻ6 expression values per group were excluded (73 probes), and transcript levels were normalized to the median expression value on each array. Webgestalt (61, 69) was used to identify overrepresented biological or molecular processes and overrepresented cellular components associated with the DR genes using P Ͻ 0.05 as the criterion for statistical significance after Benjamini-Hochberg multiple test correction of the P value, and accepting at least two genes per category (3) . Network inference of the DR genes was also performed using GeneMANIA (63), a plugin of Cytoscape (9) . BiNGO (38) , also a plugin of Cytoscape, was used for gene ontology analysis.
Genes differentially expressed as a result of cortisol treatment at each gestational age (i.e., at either 130 days or term) were determined as differentially expressed genes in 130-day CON vs 130-day CORT or 140-day CON vs 140-day CORT. Differentially expressed genes as a function of gestational age were determined by comparison of 140-day CON compared with 130-day CON. To test the hypothesis that changes in the heart produced by cortisol at 130 days reflect early maturation of normal cortisol-induced effects, we compared genes and their pathways differentially expressed in 130-day CORT vs 130-day CON septa to those differentially expressed at 140-day CON compared with 130-day CON septa. We also tested the hypothesis that genes altered by cortisol treatment to 140 days would be the same as those changed during the maturation from 130 days to 140 days gestation, i.e., that the 140-day CORT effect is simply a magnification of the normal effect of CORT near term, by comparison of DR genes in 140-day CON vs 130-day CON compared with 140-day CON vs 140-day CORT.
Array expression data for selected genes were validated by realtime quantitative PCR using TaqMan probes or Sybr Green (Applied Biosystems, Life Technologies) ( Table 1) . All primer sets were tested for PCR efficiency and for a single melting point product if SyBr Green chemistry was used.
Mitochondrial DNA. To test for changes in mitochondrial DNA (mtDNA) content, we isolated total DNA from cardiac tissue using the QIAamp DSP DNA minikit (Qiagen), according to the manufacturer's directions. mtDNA was quantified with qRT-PCR with the ovine mitochondrial gene MT-ND1 normalized against the ovine nuclear, single copy gene, AT2R (corrected for sex differences in copy number). A TaqMan probe was used for AT2R (49) and SyBr Green for the MT-ND1, both genes amplified with close to 100% efficiency, and there was a single melting point product for MT-ND1.
Markers of oxidative stress. To test for lipid peroxidation and glycosylation secondary to tissue hypoxia in the term fetal hearts, we performed Western blots. Antibodies against modified protein products of lipid peroxidation [anti-4-hydroxynonenal (HNE) Abcam 46545] and glycosylation [O-linked N-acetylglucosamine (NAG) ThermoScientific MAI-072] were used. Crude mitochondrial and cytosol preparations were prepared from left ventricle from 140-day CON and 140-day CORT by a modification of the method of Hu (22) . Heart tissue was minced in 10 volumes of buffer H (5 mM HEPES pH 7.5, 250 mM mannitol, 0.1 mM EDTA, and 0.1% BSA), spun at 300 g for 10 min, and the supernatant kept. The pellet was resuspended in the same volume of buffer H, spun again, and the supernatants pooled. After a 15 min spin at 8,000 g, the supernatant was collected as the cytosolic fraction and the pellet as the mitochondrial fraction. Protein content was determined in each fraction with the Pierce 660 nm protein assay using BSA as the standard, and then 25 g of cytosolic and 50 g of mitochondrial fractions were run on a 4 -20% Bis-Tris gel, transferred to nitrocellulose, and stained with Ponceau S. The blots were blocked with 5% nonfat dried milk, incubated with primary antibody at 1 g/ml for HNE and 1:1,000 dilution for NAG, followed by washing and the appropriate secondary antibody. Chemiluminescence was generated with Bio-Rad Immunstar, imaged with the Chemidoc XRS system and Quantity One software (Bio-Rad, Hercules, CA), and the bands' intensities normalized against total protein content of the lane. Differences in optical density were analyzed by Student's t-test.
Immunohistochemical analysis of collagen deposition and nuclear density. Tissues and sections were prepared as previously reported (4). To assess collagen deposition in the heart, sections of hearts collected from 140-day CON and 140-day CORT fetuses (n ϭ 5/group, randomly selected) were stained with picrosirius red and imaged using Image J [National Institutes of Health (NIH), Bethesda, MD] as previously described for sections from the 130-day fetuses (47) . The average area stained per section was compared by Student's t-test.
To assess nuclear density, we stained sections of the heart with 1 g/ml Hoechst 33342 (Invitrogen, Carlsbad, CA); slides were deidentified to assure that the analysis was done blind as to the experimental group of each section. Five images were captured at ϫ10 magnification from the left ventricular free wall of each heart through both bright-field and fluorescent filters. The mean of the number of nuclei per tissue area was calculated for each animal using Image J (NIH). Tissue area was calculated from bright-field images at ϫ10 after color inversion and using the Huang thresholding method to set color threshold. The DAPI-stained nuclei were counted with the particle analysis plug-in for Image J (10, 56) after conversion of the image to a 16-bit image with thresholding by the Huang method. The particle size limits were set to include the smallest nuclei observed as well as nuclei in the process of mitosis. The same threshold and size limits were applied to all images. At least 25,475 nuclei were counted within a tissue area of at least 1 mm 2 for each animal. Two cortisol-infused animals were excluded from this analysis, one for lack of tissue, and the other because of loss of tissue adhesion to the slides, perhaps due to poor fixation, resulting in group sizes of n ϭ 5 for 140-day CORT and n ϭ 8 for 140-day CON. The mean nuclei per tissue area values were compared by Student's t-test.
RESULTS

Septal genes altered by maternal cortisol treatment to 130-days gestation.
We found 447 probes to be DR in septa of 130-day CORT fetuses of cortisol-infused ewes compared with 130-day CON fetuses with no exogenous maternal cortisol infusion ( Fig. 1, top) . We could assign 430 probes unique Entrez gene IDs, and these were analyzed by Webgestalt analysis (69) . The major biological processes identified were immune system process (110 genes, P ϭ 1.92E-10), cell signaling (162 genes, P ϭ 2.58E-5), response to stimulus (235 genes, P ϭ 1.25E-7), and within these, the analysis identified overrepresented processes related to leukocyte and T-cell activation, adaptive immune response, production of cytokines and cytokine-mediated signaling, response to interferon-␥, and JAK-STAT signaling ( Table 2 ). Major molecular function categories identified were DNA binding, especially of transcriptional regulatory sites; growth factor activity; cytokine receptor binding; and protease binding. The modeling of the pathways of the genes using Cytoscape and its plug-ins Genemania, ClusterOne, and BiNGO produced similar results, albeit with some additional, predicted functions such as cellular calcium homeostasis (3 of 184 genes in the pathway, P ϭ 0.038) and apoptosis (P ϭ 0.001, 8 of 567 genes) and specifically muscle cell apoptosis (P ϭ 0.039, 1 of 4 genes). Since by 130 days, cortisol resulted in increased activated caspase-3 staining in Purkinje fibers, indicative of apoptosis (14), and the septa were enlarged by hyperplasia (47), the array analyses agree with the cardiac phenotype we had previously observed in these fetuses following maternal cortisol treatment for 10 days to 130-day gestation.
Septal genes altered by maternal cortisol treatment to term. Following a more extended increase in maternal cortisol, from 115 days to term, 513 probes were DR between the 140-day CON and 140-day CORT groups (Fig. 1, bottom) , 499 of which could be identified and were used to model pathways using Webgestalt. Immune function was again significantly overrepresented in biological process (81 genes, P ϭ 3.7E-3), molecular function, and cellular component analyses, but responses to stimuli (234 genes, P ϭ 3.7E-3), which included responses to hypoxia and to nutrients, cell death (77 genes, P ϭ 5.2E-3), and organ development, in association with mitochondrial matrix, lipid metabolism, and endoplasmic reticulum membrane, were also identified (Table 3) . Additionally, thin muscle filaments were identified as a cellular component differentially effected by CORT (Table 3) . Modeling in Cytoscape with either Genemania alone or with Genemania plus BiNGO identified response to hypoxia as the major biological function modeled (P ϭ 6.7E-6, 149 of 14,291 genes) with genes in the response to chemical stimulus, and immune system process pathways also significantly overrepresented in the 140-day CORT compared with CON groups.
We confirmed the increase in expression of several genes that are critical regulators in pathways identified by the analysis as differentially expressed at term and that were greatly increased in expression (Fig. 2) . For the response to nutrient and/or response to hypoxia pathways we confirmed that suppressor of cytokine signaling 3 (SOCS3, 604176) and cyto- (Fig. 2) . As approximately one-fifth of the genes DR in 140-day CORT were associated with mitochondria, the mitochondrial matrix was identified as a cellular component DR by 140-day CORT in Webgestalt analyses, and as mitochondria are also susceptible to hypoxic damage, we examined the mitochondrial DNA content of the hearts by RT-PCR as an index of relative mitochondrial number and found that 140-day CORT caused a significant decrease in mitochondrial DNA content in the left ventricle (Table 4) . There was no change in the number of nuclei per tissue area of the hearts with cortisol treatment to 140 days (Table 4) ; therefore, the decrease in mitochondrial DNA content is unlikely to be due to an increase in nuclear density that would increase the denominator of the ratio used to determine mitochondrial DNA content (mitochondrial genome #/nuclear genome #) to artificially cause the illusion of reduced mitochondrial number.
Maturational effects. The number of genes DR by gestational age in the comparison of the 130-day CON and 140-day CON septa was far greater than those regulated by CORT at either age; however, the common genes were not always regulated in the same direction (Figs. 3 and 4) . Similarly, the magnitudes of changes in gene expression were much greater during the maturational changes (Fig. 3) . Modeling the 87 genes that were both DR by cortisol at 130 days (130-day CORT vs 130-day CON; of 157 genes) and by gestational age (130-day CON vs 140-day CON, of 1,027 genes) showed that the cortisol-suppressed genes also downregulated with maturation were predominantly involved in regulating the immune response (P ϭ 6.47E-13), especially of responses to stress (P ϭ 2.99E-9), to cytokine-mediated signaling pathways (P ϭ 4.33E-9) and to interferon-␥ (P ϭ 6.67E-7) ( Table 5 ). Modeling of the 218 commonly upregulated genes in 130-day CORT (of 282) and increasing gestational age from 130 -140 days (of 2,576) suggests the genes induced by cortisol at 130 days reflect genes also normally induced later in gestation. These genes are involved in organ development, including the cardiovascular system (P ϭ 0.012), in regulation of increased cytosolic calcium concentration (P ϭ 0.007), and in positive regulation of muscle contraction (P ϭ 0.018), as well as in cytokine-mediated signaling (P ϭ 0.007), cell activation (P ϭ 0.007) and JAK-STAT signaling (P ϭ 0.002) ( Table 6) .
Neither the commonly up-nor downregulated genes were indicative of responses to hypoxia or nutrients, the major pathways suggested by modeling the genes DR in the 140-day CORT group, nor of muscle cell apoptosis, which was modeled with increased cortisol in the 130-day CORT group. The 60 genes changed in 130-day CORT, but not by gestational age, suggest that the cellular components affected are lysosome (10 genes P ϭ 8.4E-3), cell surface, plasma membrane, and growth cone (2 genes, P ϭ 0.04), but no biological processes or molecular functions were modeled at a significance level of P Ͻ 0.05.
Although the transcriptomic analysis suggests pathways related to the response to hypoxia are activated by excess cortisol to term, Western blot analyses with antibodies against oxidative stress markers commonly observed in hypoxic adult tissues did not show increased evidence of CORT-induced oxidative stress in 140-day CORT vs 140-day CON in cytosolic or mitochondrial fractions of left ventricle (Table 4 ). Likewise the expression of genes such as ANP, BNP, and collagens was not altered by cortisol treatment at either 130 days or term, nor was there evidence of collagen deposition in the hearts (Table 4) . The lack of decrease in nuclear number per tissue area is consistent with the lack of collagen deposition in the hearts as hypertrophy secondary to collagen deposition, as is commonly seen in hypoxic adult hearts, would reduce this ratio. . The x-axis represents the difference in the expression between cortisol and control, changes in the positive direction being greater in cortisol than control. The y-axis is the negative log of the P value, the solid line represents P ϭ 0.05, the level of significance accepted in the analyses; probes above this line were significantly differently regulated by cortisol in these septa. CON, control; CORT, cortisol; d, day.
DISCUSSION
The transcriptomic analyses of the fetal hearts suggest that chronic increases in maternal cortisol concentrations, such as may occur with maternal stress, have important consequences for the fetal heart. The chronic exposure to higher-than-normal maternal cortisol concentrations leads to changes in expression of genes, with an overrepresentation of genes related to immune function, cell signaling, and growth factor activity at 130 days, but an overrepresentation of genes related to metabolism by term.
As birth approaches, there is a significant shift in myocyte size and morphology and remodeling of the ventricles, with relative thinning of the right ventricular wall and thickening of the left ventricular free wall and with the formation of a collagenous sheath around the Purkinje fibers (7). Major cellular level changes begin in the heart before 130 days of (8), these ready the heart for the change to extrauterine life. These changes include maturation of the cardiomyocytes from a mononucleated, proliferative phenotype to a binucleated, nonproliferative, terminally differentiated phenotype, and changes in cellular collagen deposition, calcium signaling, and cellular energetics, with an increase in the number and distribution pattern of mitochondria in the cardiomyocytes (5, 39) , so that the mitochondria are exquisitely positioned to efficiently provide the ATP required for muscle contraction and impulse propagation. To accommodate this, there are also shifts in metabolism. The fetal heart relies on lactate and glucose as major energy sources in contrast to the adult heart, which relies on fatty acids; that transition occurs in the first few weeks of extrauterine life in the sheep (2, 15) . Although the fetal heart can metabolize fatty acids (2), fetal plasma levels of fatty acids are too low to be a useful source of energy. It is also probable that fetal oxygen levels are insufficient to effectively metabolize fats, because although the amount of ATP generated by fatty acid beta oxidation is greater than that from metabolism of lactate or glucose, the efficiency per mole of oxygen is less. Overall there are extensive cellular changes in late fetal heart development that are known to be controlled, at least indirectly, by the prepartum cortisol surge (53) . The present results demonstrate that a modest, but chronic, increase in cortisol such as generated in our studies might influence normal cardiac maturation and function though effects on fetal cardiac metabolism. One hypothesis for the effects of cortisol on the fetal heart was that increasing cortisol 1.5-fold between 120 and 130 days gestation (47) produces cardiac enlargement primarily by accelerating the normal late-gestational maturation of the heart; however, the transcriptomic analysis suggests that although some genes altered by cortisol at 130 days are those altered at 140 days in the control fetuses, this hypothesis is an oversimplification of the effect of cortisol on the fetal heart. In our earlier studies the effects of maternal cortisol did not correspond to the changes found with maturation when a subset of genes related to IGF and angiotensin were considered (48, 49) .
In this more extensive comparison using gene array, we found that some of the genes up-or downregulated in both 130-day CORT and in the normal maturation of the heart are changed in the same direction, the upregulated genes apparently involved in the maturation of the heart (suggested by gene ontology terms such as organ and cardiovascular system development) and the downregulated in modulation of the immune system in the heart (cytokine signaling and interferon-␥ responses). The common upregulated genes have diverse actions, including calcium channel signaling and chemokine receptor expression, and suggest cortisol might contribute to maturation by mechanisms previously identified as GR-related in the mouse (53) . The downregulated genes, while consistent with the known ability of cortisol to dampen immune responses in the adult (42) , suggest that there may be a requirement for modulation of immune processes for the proper development of the heart during late gestation. However, there are many genes that are either unchanged in one group compared with the other or changed in the opposing direction by cortisol compared with the changes occurring during normal maturation. The analyses of the genes whose expression was affected in 130-day CORT, but not during maturation, indicate potential effects on the plasma membrane and specifically the growth cone. While it is tempting to hypothesize that this might underlie the Purkinje cell apoptosis we had previously observed in 130-day CORT, we did not examine the growth cones of the cardiac nerves, nor were many genes involved in these pathways, making the significance of the results unclear. Nonetheless, after only 10 days of infusion, a modest increase in fetal cortisol appears to induce genes with possible deleterious effects, as well a number that would later be induced in the course of normal maturation. Previous studies from our laboratory (49) had also suggested that the effects seen in 130-day CORT were not through induction of genes associated with known inducers of cardiomyocyte proliferation such as IGFs or angiotensin, nor was the pattern similar to that seen for other genes near term (58, 59) . The effects of cortisol also were dissimilar to those commonly observed in the enlarged mature heart such as collagen deposition or hypertrophy in response to increased afterload from hypertension. This difference is consistent with the fact that these cortisol concentrations are not high enough to increase fetal arterial pressure, and there was no ischemic event in these hearts. The gene array also did not identify changes in pathways associated with hypertrophic growth or ischemia. Expression of ANP or BNP and collagen content, indicators of heart failure in adults, were also not significantly changed. Indeed, microarray analyses followed by gene pathway modeling were employed to try to understand the mechanism of action of cortisol, as the previously hypothesized mechanisms of cortisol in maturation did not seem to be involved in the observed effects of cortisol.
Transcriptomic analysis also did not support the hypothesis that longer periods of cortisol exposure to term would exacerbate the cortisol effects occurring at 130 days. The pathways activated by cortisol, as modeled by comparison of 140-day CORT vs 140-day CON, suggested responses to hypoxia and to nutrients were altered and that these could involve mitochondria, lipid metabolism, and the endoplasmic reticulum. These responses were not modeled as effects of cortisol at 130-day CORT. However, we saw no evidence of fetal hypoxemia produced in the earlier studies with maternal infusion of cortisol to 130 days (24, 47) , suggesting that chronic hypoxemia does not occur in this model with rather modest hyperglycemia. Although it is possible that the enlargement of the heart muscle, if not in concert with development of blood vessels to supply adequate oxygen and nutrients to the heart, could lead to tissue hypoxia and nutrient deficits, the hypoxiainduced genes HIF1␣ and ARNT aryl hydrocarbon receptor nuclear were not altered on the array. Of the 27 "hypoxia"-related genes, six of these were also in the nutrient pathway, and many others, including placental growth factor, corticotropin-releasing hormone receptor 1, and caveolin 1, are not specifically hypoxia related. In the 140-day hearts we did not find evidence of proteins modified by either lipid peroxidation or O-linked N-glycosylation end products as would be expected following production of reactive oxygen species, which could result after acute hypoxia. Thus it is perhaps more likely that the 140-day CORT effects are responses to changes in nutrient supply, i.e., adaptations to the chronic hyperglycemia secondary to cortisol-induced hyperglycemia in the ewe (24) . Supporting this hypothesis is the increased expression of four genes, PDK4, TXNIP, SOCS3, and CYP26B1, known to alter cellular metabolism, increase insulin resistance, or decrease glucose utilization in the 140-day CORT septa. PDK4 is a gene regulated by both insulin and cortisol; PDK4 decreases pyruvate entry into the TCA cycle by phosphorylating and thereby inactivating the pyruvate dehydrogenase complex (25) . TX- Fig. 4 . Volcano plots of the expression distribution of the probes on the array in the fetal septa, illustrating the maturational effects (difference between 140-day CON and 130-day CON, OE) with the probes altered in 130-day CORT (difference of 130-day CORT and 130-day CON) (top) or 140-day CORT (difference of 140-day CORT and 140-day CON) (bottom) shown in colors. Probes significantly differentially expressed with maturation are drawn above the solid line (P Ͻ 0.05). The red symbols are those probes whose expression was significantly increased by CORT (P Ͻ 0.05, at 130 day, top, or at term, 140 days, bottom) (i.e., 140 days vs 130 days in CON fetuses). The green symbols are the probes significantly decreased by CORT (P Ͻ 0.05; 130-day CORT, top, or 140-day CORT, bottom). Note that some genes are changed by CORT, but not by maturation (colored symbols below the significance line), and some were changed in the opposite direction by CORT compared with the effect of gestational age (e.g., red symbols on the negative x-axis side of the volcano plot, or green symbols on the positive x-axis side of the plot). In all cases y-axis values reflect the P values for gene expression due to the maturational effect.
NIP, which may function as a metabolic control protein in the heart (67), has recently been shown to increase insulin resistance and decrease insulin sensitivity in bone tissue from Cushing's disease patients (34) . Increased expression of CYP26B1, which metabolizes all trans retinoic acid, may decrease glucose uptake (33) . In cardiomyocytes subjected to hyperglycemia, retinoic acid/retinoid X receptor (RAR/RXR) signaling is impaired, leading to apoptosis through oxidative stress and NF-B signaling (44, 57) ; however, in these fetal hearts increased breakdown of retinoic acid by CYP26B1 may reduce RAR/RXR activation, leading to apoptosis. Finally, SOCS3 limits glucose uptake by interfering with phosphorylation events downstream of the insulin receptor (13) . Therefore, the gene expression pattern suggests that the 140-day CORT septa have impaired glucose uptake and metabolism.
The results of the transcriptomic analysis suggest that in the face of increased glucose levels, downregulation of carbohydrate metabolizing pathways protect the heart from damage due to oxidative stress, allowing adaptation until labor. The gene expression patterns at 140 days suggest that the stillbirth of these lambs may result from inadequate metabolic capacity of the heart as labor and delivery progress. The fetal heart withstands even rather severe chronic hypoxia without failing (50, 51) , so it is unlikely that chronic hypoxia directly contributes to the fetal demise or to the transcriptomic patterns found in these hearts. However, acute hypoxia occurring secondarily to labor, coupled with the decrease in mitochondrial number in the 140-day CORT hearts, could decrease the efficient functioning of the fetal heart, potentially to the point of failure. Fetal sheep have been shown to have more pronounced bradycardic responses to hypoxia at term than at 125-130 days gestation (17) . Studies in which ewes were infused or injected with dexamethasone have found that glucocorticoid exposure prolongs the bradycardia and vasoconstriction in response to acute hypoxia and increases the severity of acidemia (16, 23) ; in those studies it was suggested that the effect of glucocorticoid was to exaggerate both parasympathetic and sympathetic responses. Our array results suggest an effect of cortisol to alter energy availability in the heart at term, which may contribute to, or exaggerate, the bradycardia at term after chronic exposure to cortisol. Interestingly, the array results indicate that there was no increase in expression of the mitochondrial biogenesis markers PPARGC1A (604517), SIRT1(604479), SIRT3 (604481), NOS3 (163729), NRF1 (600879), TFAM (20) as a result of the maternal cortisol infusion in the term hearts, suggesting that there is no drive to correct the apparent deficit in mitochondrial number. The transcriptomic response suggests that cardiac insulin resistance may also occur as an adaptation to chronic hypercortisolemia. Cardiac insulin resistance is observed in the rat prior to the heart failure associated with pressure overload hypertrophy and manifests as decreased insulin-stimulated glucose oxidation and glycolysis and decreased mitochondrial oxidative metabolism (70) . If the 140-day CORT hearts are insulin resistant, they could be prone to fail at term as left ventricular afterload increases at birth. Indeed this is a potential explanation for the perinatal outcome, as eight of 15 fetuses in the cortisol-infused ewes died after the start of labor or in the immediate postpartum period. These results in the hypercortisolemic, and presumably hyperglycemic fetus, appear to be in contrast to those in fetuses with growth restriction secondary to placental restriction. In placental restriction the overall fetal growth is compromised, but heart weight-to-body weight ratio is maintained, albeit with relatively more mononucleated cardiomyocytes and relatively larger cardiomyocytes (43) , suggesting delayed transition to the terminally differentiated phenotype. In these hearts IGF-2 and IGF receptor expression is more abundant (62) . These gene changes appear to be growth-sparing adaptations to sparsity of nutrients secondary to placental restriction, whereas in the fetuses of hypercortisolemic ewes changes in gene expression occur in the midst of plentiful glucose and may be growthlimiting adaptations. Some developmental effects of cortisol are thought to be mediated indirectly by other factors, including thyroid hormone. Both the endogenous increase in cortisol and exogenous glucocorticoid treatment increase thyroid hormones in the fetus (18, 19) . We therefore considered whether the effects of increased maternal cortisol found in fetuses at either 130 days or at term could be mediated through a direct effect of cortisol at the classical glucocorticoid response element (GRE) or indirectly through the thyroid hormone transcription factor. Neither GRE nor thyroid hormone response element was suggested as the predominant transcription factor by transcription factor analysis with Webgestalt. Of the genes differentially expressed as a result of maternal cortisol treatment to 130 days, there were no genes with GRE, and the T3 receptor (T3R) was a transcription factor targeting only seven genes (of 248 known T3R-regulated genes in the ontology databases, adjusted P value ϭ 0.03). At term, the classical GRE was recognized as a transcription factor for 10 genes DR by cortisol (of 276 possible genes with GRE, adjusted P value ϭ 0.0045) as was the T3R (10 genes of 248, adjusted P valueϭ 0.0027). These findings suggest that cortisol-activated receptors may act primarily via protein-protein interactions with other transcription factors or that cortisol is acting indirectly for example through cortisol-mediated maternal, and the resultant fetal, hyperglycemia. Interestingly, the estrogen-related receptor 1 (ESRRA) was implicated in control of genes DR by cortisol at both 130 days and term. ESRRA is a member of the ESRR family of orphan receptors that has been shown in the mouse and in human hearts (30) to have profound effects coordinating cardiac metabolism, structure, and function (1, 11) and regulates thyroid hormone receptor synthesis (60) . ESRRA was a suggested transcription factor for 26 DR genes of a possible 1,023 regulated by ESRRA, adjusted P value ϭ 0.0002 at 130 days, and of 38 genes (of 1,023) at 140 days with an adjusted P value of 1.35E-8, suggesting that ESSRA has more importance than the GRE or T3R. The ESRR family member ESRR␥, which interacts with, or possibly is redundant to, ESRRA (11) , regulates the expression of PDK4 (32) , one of the genes upregulated by cortisol at 140 days, although in the transcription factor analysis PDK4 was not shown in the ESRRAregulated genes. ESRRA has an important role, in concert with PPARGC1A, in regulating mitochondrial function (1, 40) , including fission and fusion (35) and mitochondrial phospholipid synthesis (31) , suggesting that ESSRA may play an important role in the mechanism by which increased maternal cortisol leads to decreased septal mitochondrial DNA content. But, as there is no published evidence to show that cortisol regulates the expression of the ESRRs, it is probable that this is an indirect effect mediated through the maternal and fetal hyperglycemia secondary to hypocortisolemia.
Thyroid hormone has also been shown to have effects on the fetal or neonatal heart that are not mediated by the classical TRE. Thyroid hormone mediates the switch from the fetal to adult form of TTN (titin), an important protein in the contractile apparatus of the heart, via increased phosphorylation of Akt (28, 29) . Thyroid hormone also suppresses mitotic activity of growth factor-stimulated cardiomyocytes by increasing the activity of CDKN1A (p21) and decreasing the activity of CCND1 (cyclin D1) (8) . Transcription factor modeling would miss this type of thyroid hormone action. But while our transcriptomics analyses did not indicate enrichment of Akt pathways following maternal cortisol treatment, at 140 days, CCND1 expression was significantly increased by cortisol and was part of the response to nutrient pathway. This suggests that cortisol would delay the terminal differentiation of the cardiomyocytes, an opposite action to that of T3. Incidentally, the expression of TTN was not affected by maternal cortisol treatments but was increased during the maturation from 130-to 140-days gestation. Nonetheless, it would be interesting to examine the subtypes of TTN in the fetuses of cortisol-infused ewes, as the stiffness of the heart is regulated in part by the proportions and phosphorylation status of the TTN subtypes present in the heart.
Our studies have indicated that chronic increases in cortisol during pregnancy, outside of the normal late-gestational window that is so important for proper fetal development, have potentially disastrous effects on fetal survival at birth (27) . In those hearts transcriptomic analysis indicates effects of chronic exposure to increased cortisol that overlap with, but are largely distinct from, the effects of normal cardiac maturation. More importantly, the results indicate that chronically increased maternal cortisol stimulates a shift in cardiac metabolism that mirrors some aspects of the failing adult heart and that could prove maladaptive during labor and the immediate neonatal period. We conclude that these molecular responses might explain the increased incidence of stillbirth in pregnancies complicated by Cushing's disease or diabetes and suggest that metabolic support to the heart during this period could be beneficial.
